American International Group’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-19,889
Closed -$983K 2038
2024
Q1
$983K Sell
19,889
-171
-0.9% -$8.14K ﹤0.01% 1311
2023
Q4
$841K Buy
20,060
+2,046
+11% +$69.7K ﹤0.01% 1394
2023
Q3
$591K Buy
18,014
+640
+4% +$21.8K ﹤0.01% 1505
2023
Q2
$614K Buy
17,374
+4,864
+39% +$161K ﹤0.01% 1517
2023
Q1
$355K Buy
12,510
+249
+2% +$8.78K ﹤0.01% 1792
2022
Q4
$509K Buy
12,261
+107
+0.9% +$4.59K ﹤0.01% 1578
2022
Q3
$504K Buy
12,154
+171
+1% +$6.82K ﹤0.01% 1565
2022
Q2
$392K Buy
11,983
+8,394
+234% +$305K ﹤0.01% 1773
2022
Q1
$126K Sell
3,589
-252
-7% -$6.06K ﹤0.01% 2495
2021
Q4
$96K Buy
+3,841
New +$142K ﹤0.01% 2735

Other funds holding PRCT

American International Group's PRCT Position: Q2 2024 in Review

American International Group sold out of Procept Biorobotics (PRCT) in Q2 2024, closing a stake of 19,889 shares — an estimated $983K sold.

American International Group first reported a position in PRCT in Q4 2021 and held it in 10 quarters. The position peaked at $983K in Q1 2024. 201 funds tracked by Wall St. Rank hold PRCT as of Q2 2024.

  • American International Group reported no remaining Procept Biorobotics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 19,889 Procept Biorobotics shares in Q2 2024, an estimated $983K.
  • American International Group first reported a position in Procept Biorobotics in Q4 2021 and held it in 10 quarters.
  • American International Group's Procept Biorobotics position peaked at $983K in Q1 2024.
  • 201 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.